{
    "clinical_study": {
        "@rank": "70527", 
        "acronym": "AL-EN-PHED", 
        "arm_group": {
            "arm_group_label": "RealDiet\u00aeRenal enteral nutrition", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The objective of this unblinded study is to assess the nutritional effects of a 12 weeks\n      administration of the specific enteral nutrition (SEN) RealDiet\u00aeRenal pockets, as well as\n      the impact on the patients' quality of life."
        }, 
        "brief_title": "Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Kidney Disease", 
            "Renal Failure Chronic Requiring Hemodialysis", 
            "Severe Malnutrition", 
            "Tolerance", 
            "Quality of Life", 
            "Activity", 
            "Appetite and General Nutritional Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Kidney Failure, Chronic", 
                "Nutrition Disorders", 
                "Renal Insufficiency", 
                "Malnutrition", 
                "Renal Insufficiency, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic kidney disease patient on hemodialysis for at least 3 months, with a minimum\n             of three hemodialysis sessions of 4 hours per week\n\n          -  Patients aged 18 years\n\n          -  Written, free and informed consent given by the Patient\n\n          -  Patient insured under the social security system or equivalent\n\n          -  Patients who did not receive enteral nutrition during the 3 months preceding\n             inclusion ; taking an oral nutritional supplement, or per-dialytic parenteral\n             nutrition or total parenteral nutrition is not a criterion of non-inclusion\n\n          -  Patient in a state of malnutrition\n\n               -  defined by the presence of at least 3 out of 5 of the following criteria :\n\n                    -  weight loss greater than 10% observed in the last six months\n\n                    -  serum albumin <35 g / l\n\n                    -  serum Prealbumin <300 mg / l\n\n                    -  BMI <20\n\n                    -  NPNA <1 g / kg / day for 2 consecutive months\n\n        and\n\n          -  presenting\n\n               -  food intake <20 kcal / kg / day or\n\n               -  failure of other nutritional care methods, namely, oral nutritional supplements\n                  and / or peridialytic parenteral nutrition, or total parenteral nutrition\n\n               -  lack of compliance after one month, to the nutritional care methods mentioned\n                  above. \u2022 Patients for whom the decision to prescribe enteral feeding was\n                  previously taken\n\n        Exclusion Criteria:\n\n          -  Patients with a history of intolerance to enteral feeding\n\n          -  Index Kt/Veq (balanced) < or = 1.2 or index Kt/Vsp (single pool) < or = 1.4 according\n             to the method used\n\n          -  Patients with a disease compromising the short-term (4-6 months) prognosis (cancer or\n             other disease in the terminal phase)\n\n          -  Pregnant Patient\n\n          -  Patient with a known allergy to at least one of the following : milk protein, soy,\n             fish\n\n          -  Patient whose digestive tract is not functional or patient in shock\n\n          -  Patient protected under guardianship\n\n          -  Patient in exclusion period after participation in another clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946841", 
            "org_study_id": "LRD - 2013 - ALENPHED"
        }, 
        "intervention": {
            "arm_group_label": "RealDiet\u00aeRenal enteral nutrition", 
            "intervention_name": "RealDiet\u00aeRenal", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic kidney disease", 
            "Hemodialysis", 
            "Severe malnutrition", 
            "Enteral nutrition"
        ], 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "contact": {
                "email": "jacqueline.brasy@lactalis.fr", 
                "last_name": "Jacqueline Brasy", 
                "phone": "+33299475084"
            }, 
            "facility": {
                "address": {
                    "city": "Retiers", 
                    "country": "France", 
                    "zip": "35240"
                }, 
                "name": "Lactalis"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effets de la Nutrition ent\u00e9rale sp\u00e9cifique RealDiet\u00aeRenal (NES) Chez Des Patients Insuffisants r\u00e9naux h\u00e9modialys\u00e9s d\u00e9nutris : efficacit\u00e9, tol\u00e9rance, qualit\u00e9 de Vie.", 
        "overall_contact": {
            "email": "jacqueline.brasy@lactalis.fr", 
            "last_name": "Jacqueline Brasy", 
            "phone": "+33 299475084"
        }, 
        "overall_contact_backup": {
            "email": "pascale.leruyet@lactalis.fr", 
            "last_name": "Pascale Le Ruyet", 
            "phone": "+33 299475099"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate during 3 months specific enteral nutrition (SEN) treatment, and 3 months after treatment interruption, the effects of the study product on the evolution of serum prealbumin and albumin.", 
            "measure": "Evolution of serum prealbumin and albumin.", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946841"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Evolution of nutritional status during 3 months of enteral nutrition, and during 3 months after end of treatment.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Evolution of quality of life during 3 months of enteral nutrition, and during 3 months after end of treatment.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Evolution of tolerance of study product during 3 months of enteral nutrition.", 
                "safety_issue": "Yes", 
                "time_frame": "3 mois"
            }
        ], 
        "source": "Lactalis", 
        "sponsors": {
            "collaborator": {
                "agency": "Clinact", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Lactalis", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}